Cite
HARVARD Citation
Sorin, V. et al. (2012). H19-Promoter-Targeted Therapy Combined with Gemcitabine in the Treatment of Pancreatic Cancer. ISRN oncology. p. . [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Sorin, V. et al. (2012). H19-Promoter-Targeted Therapy Combined with Gemcitabine in the Treatment of Pancreatic Cancer. ISRN oncology. p. . [Online].